Remarkably, circulating TNFR2 levels are robust predictors of early and late renal function decline leading to ESRD in type 1 and type 2 DN patients (Carlsson et al., 2016; Niewczas et al., 2019). The gene discussed is TNFRSF1B; the disease is liver dysplastic nodule.